Exciting Catalysts Approaching for This Bet
Motley Fool
Vivus Seeing Traction With Qsymia
Seeking Alpha
Vivus Gets Restrictions Loosened
Seeking Alpha
An Obesity Drugmaker's Critical Coming Weeks
Motley Fool
How Doctors Actually Diagnose Obesity
Motley Fool
Should Anti-Obesity Drug Company Stocks Trade In Tandem?
Seeking Alpha

